VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 21 of 34
Cognitive Training in the Treatment of AUD
NCT02664038
Primary Care Intervention to Reduce Prescription Opioid Overdoses
NCT02464410
Biological Signatures, Probiotic Among Those With mTBI and PTSD
NCT02723344
Integrating Pharmacogenetics In Clinical Care
NCT02871934
Powered Exoskeletons in Persons With SCI
NCT02658656
Long-Term Effectiveness of Walking Training in Patients With Knee Osteoarthritis
NCT02767570
Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD)
NCT02475954
Evaluation of Web-Based CBT for Women Veterans With PTSD
NCT02917447
Orthotic Dose Response Study
NCT02629731
ASPIRE Cognitive Enhancement Study
NCT02657954
Physical Activity Behavior Change for Older Adults After Dysvascular Amputation
NCT02738086
A Proactive Walking Trial to Reduce Pain in Black Veterans
NCT01983228
STepped Exercise Program for Knee OsteoArthritis
NCT02653768
Encouraging Patient-Centered Communication in Clinical Video Telehealth Visits
NCT02522494
Diuretic Comparison Project
NCT02185417
Using Emotion Regulation to Decrease Aggression in Veterans With PTSD
NCT02724787
Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD
NCT03647137
Exercise Training in Heart Failure: Changes in Cardiac Structure and Function
NCT02275819
Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms
NCT02769338
CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
NCT02500602
Albuterol to Improve Respiratory Strength in SCI
NCT02508311
Adjunctive Mood Management for Telephone-based Smoking Cessation
NCT02500589
Delivery Models of Caregiver Support and Education
NCT02368132
CAM in Veterans With Gulf War Illnesses
NCT02180243
Neural Adaptation After Tendon Transfer and Training in Tetraplegia
NCT02768103
Shared Health Appointments and Reciprocal Enhanced Support
NCT02132676
CAP-Ketamine for Antidepressant Resistant PTSD
NCT02655692
Justice-Involved Veterans and Moral Reconation Therapy
NCT02524171
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
NCT02697435
Improving Function in Older Veterans With Hospital-Associated Deconditioning
NCT02696382
TOP Implementation Project
NCT02737098
Cognitive-Behavioral Therapy for Veterans With TBI
NCT02658669
Virtual Reality Rehabilitation for Individuals With Lower Limb Amputation
NCT02328859
Theta-Burst Neuromodulation for PTSD
NCT02769312
Influence of Exercise, Weight Loss, and Exercise Plus Weight Loss on Sleep Apnea
NCT02721251
Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers
NCT02386605
Crisis Line Facilitation
NCT02459587
A Patient-Centered Intervention to Improve Opioid Safety
NCT02791399
Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization
NCT02689076
Enhancing STDP After Spinal Cord Injury
NCT02701777
Quality Improvement and Personalization for Statins
NCT02820870
Shifting Rehabilitation Paradigms in Skilled Nursing Facilities
NCT02927171
Optimal Treatment for Recurrent Clostridium Difficile
NCT02667418
Maintaining Independence and Sobriety Through Systems Integration, Outreach, and Networking
NCT02942979
Effect of Exercise in Parkinsonism
NCT02598973
eHealth Partnered Evaluation Initiative
NCT02665468
Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy Study
NCT01918774
Neurophysiological and Kinematic Predictors of Response in Chronic Stroke
NCT02658630
Fatiguing Arm Exercise Following Stroke
NCT03194464
Dietary Carbohydrate and GERD in Veterans
NCT02384551
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.